| | Reference | Immunophenotype |
| | Akpinar et al. [21] | CD13+, CD29+, CD44+, CD73+, CD90+, CD146+, CD166+ | |
Suchánek et al. [22] | CD29+, CD44+, CD63+, CD73+, CD90+, CD166+, CD45−, CD34− | | Kawashima [23] | CD29+, CD44+, CD73+, CD105+, CD166+, CD14−, CD34−, CD45−
Stro-1+, CD29+, CD44+, CD73+, CD90+, CD105+, CD146+, CD166+, CD271+, CD34+, CD117+, OCT-3/4+, NANOG+ | | Werle et al. [24] | CD29+, CD73+, CD90+, CD14−, CD34−, CD45−, HLA-DR− | | Bray et al. [25] | CD44+, CD73+, CD90+, CD105+, CD14−, CD31−, CD45−, HLA-DR− | | Govindasamy et al. [26] | CD44+, CD73+, CD90+, CD166+, CD34−, CD45−, HLA-DR− | | Lindemann et al. [27] | CD73+, CD90+, CD29+, CD14−, CD34−, CD45−, HLA-DR− | | Pivoriūnas et al. [28] | CD73+, CD90+, CD105+, CD146+, CD14−, CD34−, CD45− | | Laino et al. [29] | CD90+, CD34+, CD45− | | Lindroos et al. [30] | CD90+, CD105+, CD146+, CD9+, CD10+, CD44+, CD49+, CD106+, STRO-1+ | | Shoi et al. [31] | CD90+, CD105+, CD146+, CD45− | | Ishkitiev et al. [32] | CD117+, Oct3/4+, NANOG+ | | Yang et al. [33] | CD117+, CD34+, CD45− | | Jo et al. [34] | STRO-1+, CD29+, CD44+ | | Liu et al. [35] | STRO-1+, CD29+, CD34+, CD44+, CD106+, CD146+ | | Dissanayaka et al. [36] | STRO-1+, CD146+, NANOG+, CD73−, CD105−, CD45− | | Kerkis et al. [37] | OCT-4+, NANOG+, SSEA-3+, SSEA-4+, TRA-1-60+, TRA-1-81+ |
|
|
